Sentences with phrase «including breast cancer research»

Emergen - C also supports causes, including breast cancer research, awareness and prevention, as well as organizations that are making a difference in the world, such as the Surfrider Foundation ®.

Trailheads also donates 3 % of annual sales to charitable partners including the Breast Cancer Research Foundation, National Sports Center for the Disabled, and Guiding Eyes for the Blind.

When you purchase any of the zesty products listed there, the manufacturers donate a portion of the proceeds to various charities and nonprofits including breast cancer research, protection of endangered species, church youth groups & missions, soup kitchens & families in need, animal shelters and rescue groups.

Not exact matches

In this talk, Natalie presents the latest state of research into the links between breast feeding and breast cancer, including the latest evidence for risk reduction and our understanding of how pregnancy - associated breast cancer develops.

Responding to a review of 19 research papers, funded by Cancer Research UK, which reported information on cancer false alarms and the impact on people reporting future symptoms, including six carried out in the UK, Davinia Green, Head of Breast Awareness and Early Detection at Breast Cancer Carresearch papers, funded by Cancer Research UK, which reported information on cancer false alarms and the impact on people reporting future symptoms, including six carried out in the UK, Davinia Green, Head of Breast Awareness and Early Detection at Breast Cancer Care,Cancer Research UK, which reported information on cancer false alarms and the impact on people reporting future symptoms, including six carried out in the UK, Davinia Green, Head of Breast Awareness and Early Detection at Breast Cancer CarResearch UK, which reported information on cancer false alarms and the impact on people reporting future symptoms, including six carried out in the UK, Davinia Green, Head of Breast Awareness and Early Detection at Breast Cancer Care,cancer false alarms and the impact on people reporting future symptoms, including six carried out in the UK, Davinia Green, Head of Breast Awareness and Early Detection at Breast Cancer Care,Cancer Care, says:

NBCC's mission includes increasing awareness about breast cancer, training people to be grassroots activists and increasing federal funding for research.

Women with a mental illness (including depression, anxiety and serious mental illnesses) are less likely to be screened for breast cancer, according to new research published in the BJPsych (online first).

The research team, including Soumen Paul, Ph.D., associate professor, Arindam Paul, Ph.D., assistant professor, and Ossama Tawfik, professor, M.D., Ph. D., all in the Department of Pathology and Laboratory Medicine, and their colleagues, studied atypical protein kinase c lambda / iota signaling during the invasive progression of triple - negative breast cancer.

Readers will have at their fingertips key articles in the history of science from the late 19th through the early 21st centuries, including research about the human genome, breast and colon cancer genes, and the Bose - Einstein condensate in physics.

These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances in the use of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.

Its research includes a cluster of related interdisciplinary projects that examine disparities in breast cancer mortality between African - American and Caucasian women using animal models, molecular characterization of tumors, and behavioral research focused on social - environmental factors.

Her research, published in the International Archives of Occupational and Environmental Health, examined key studies that included risk factors for developing breast cancer.

Supported by the Basser Research Center for BRCA in Penn's Abramson Cancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related caCancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related cacancer types, including ovarian and breast cancers — the two major BRCA - related cancers.

Dr Wells» team has previously published research on the importance of PAK4 in other types of cancer, including prostate, breast and melanoma.

Funders of the work include the Department of Defense Breast Cancer Research Program, the National Institutes of Health, the Sidney Kimmel Foundation, and the UCSF Program in Breakthrough Biomedical Research.

Dr. Konstantinos Tryfonidis, EORTC Clinical Research Physician and lead author of this review says, «Locally advanced breast cancer is a term that includes a wide variety of breast tumors ranging from large operable cancers with extensive nodal involvement to inflammatory breast carcinomas.

A University of Colorado Cancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug covCancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug covBreast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug covCancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug covbreast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug covcancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug coverage.

The researchers, including scientists from The Genome Institute at Washington University School of Medicine, presented the research titled, «Patient - derived xenograft study reveals endocrine therapy resistance of ER + breast cancer caused by distinct ESR1 gene aberrations.»

A team including scientists at The Institute of Cancer Research, London, found that women whose breast cancer had begun to spread and who tested positive in the αB - crystallin test were three times more likely to have disease that spread to the brain than those who tested negCancer Research, London, found that women whose breast cancer had begun to spread and who tested positive in the αB - crystallin test were three times more likely to have disease that spread to the brain than those who tested negcancer had begun to spread and who tested positive in the αB - crystallin test were three times more likely to have disease that spread to the brain than those who tested negative.

Dr Julie Sharp, Cancer Research UK's head of health information, said: «This study further highlights that however you measure it being overweight or obese can increase the risk of developing certain cancers, including breast and bowel.

In addition, the study, led by investigators in The Cancer Genome Atlas (TCGA) Research Network, revealed four novel tumor subtypes, while also identifying genomic similarities between endometrial and other cancer types, including breast, ovarian, and colorectal caCancer Genome Atlas (TCGA) Research Network, revealed four novel tumor subtypes, while also identifying genomic similarities between endometrial and other cancer types, including breast, ovarian, and colorectal cacancer types, including breast, ovarian, and colorectal cancers.

(13) Existing law establishes various health research grant programs, including the Cancer Research Program, the Breast Cancer Research Program, and the Spinal Cord Injury Research research grant programs, including the Cancer Research Program, the Breast Cancer Research Program, and the Spinal Cord Injury Research Research Program, the Breast Cancer Research Program, and the Spinal Cord Injury Research Research Program, and the Spinal Cord Injury Research Research Program.

In addition to the inherited breast and ovarian cancer, her research interests include genetics of hearing loss, the genetic bases of schizophrenia, genetics of systemic lupus erythematosus, and human genetic diversity and evolution.

Her research areas included breast cancer, endocrine disruption and tissue engineering.

This week's headlines include: GSK slims portfolio with sale of rare disease gene therapy drugs, The Focus Shifts in Alzheimer's Research, Healing process after breast cancer surgery may trigger...

Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in human solid tumors, including brain, breast, prostate, pancreas, liver, ovary, skin, colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andBreast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andCancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andbreast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

This has included building programs in community - based participatory research, as well as Program - directed strategies on environmental links to, and disparities in, breast cancer.

His research has included studies of cancer around nuclear facilities, cancer and other diseases in military veterans, occupational causes of cancer including breast cancer, among other topics.

Included among the numerous recipients of Mr. Sanford's gifts, that total more than one billion dollars, are: the Edith Sanford Foundation for Breast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MedBreast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MedCancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medbreast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medcancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medicine.

The research covers a broad range of cancer types, including breast, prostate, leukemia, glioma, pancreatic, sarcoma, lung and melanoma.

Background In our institute, the first research program on disseminated tumor cells (DTC) detection in the bone marrow of early breast cancer patients was initiated in the late 90's; with about a thousand patients included, we constituted one of the largest cohort ever reported and contributed to the landmark report that established bone marrow DTC as a level - of - evidence 1 prognostic factor in early breast cancer (Braun, N Engl J Med 2005).

Dr. Chung directs NIH funded research programs in human genetics of obesity, breast cancer, pulmonary hypertension, and birth defects including congenital diaphragmatic hernia and congenital heart disease.

Long - term use of aspirin is associated with lower risk of dying from various types of cancers, including colorectal, lung, breast and prostate cancer, according to a study presented at the 2017 American Association for Cancer Research annual mecancer, according to a study presented at the 2017 American Association for Cancer Research annual meCancer Research annual meeting.

The Kimmel Cancer Center also participates in other cancer clinical trials consortia, including those for prostate, breast, and bone marrow cancers, immunotherapy, and the Hoosier Cancer Research NeCancer Center also participates in other cancer clinical trials consortia, including those for prostate, breast, and bone marrow cancers, immunotherapy, and the Hoosier Cancer Research Necancer clinical trials consortia, including those for prostate, breast, and bone marrow cancers, immunotherapy, and the Hoosier Cancer Research NeCancer Research Network.

His research includes, uncovering the complex transcriptional network that exists in the tumor microenvironment roles of cancer initiating cells in immune suppresion, understanding the mechanism of T cell anergy and molecular analysis of T cell repertoire of patients with breast cancer.

Her research interests include both clinical and translational breast cancer - related research.

Dr. Meszoely has contributed to several research journals, including the Annals of Surgical Oncology, Cancer Cell and The Cancer Journal, and is a member of the American Society of Clinical Oncology, American Society of Breast Surgeons, American Society of Clinical Research, American College of Surgeons and the Society of Surgical Oresearch journals, including the Annals of Surgical Oncology, Cancer Cell and The Cancer Journal, and is a member of the American Society of Clinical Oncology, American Society of Breast Surgeons, American Society of Clinical Research, American College of Surgeons and the Society of Surgical OResearch, American College of Surgeons and the Society of Surgical Oncology.

The main focus of my research program is on design and preclinical evaluation of novel therapeutic strategies for treatment of metastatic cancers, including breast cancer and melanoma.

Prior to working at City of Hope, she worked as a research associate in Dr. Peter Lee's lab at Stanford University since 2006 and facilitated in investigating mechanisms causing immune dysfunction in melanoma and breast cancer patients» peripheral blood, lymph node and tumor specimens utilizing techniques including microarray analysis, RT - PCR, Phospho - flow cytometry, histoloogy, and functional FACS studies.

â $ For a small subgroup of women with strong family histories of breast cancer, we recommend starting screening, including annual mammograms and MRIs, at age 25, â $ says Julie R. Gralow, MD, the director of breast medical oncology at the University of Washington and Fred Hutchinson Cancer Research Center in Secancer, we recommend starting screening, including annual mammograms and MRIs, at age 25, â $ says Julie R. Gralow, MD, the director of breast medical oncology at the University of Washington and Fred Hutchinson Cancer Research Center in SeCancer Research Center in Seattle.

Research has linked alcohol to at least six cancers, including colon, breast, liver and esophageal.

Kwan's research extends these findings to include the risk of recurrence among women who have already been diagnosed and treated for breast cancer, a population that numbers about 2.5 million in the United States, according to the American Cancer Socancer, a population that numbers about 2.5 million in the United States, according to the American Cancer SoCancer Society.

This has been seen in various studies, including one large research project called «the Million Woman» study and the nurses health study, which showed a connection to breast cancer and also an increased risk of heart disease and stroke in women using hormone replacement therapy.

The World's Healthiest Foods has this to say about strawberries: «Given their unique combination of antioxidant and anti-inflammatory nutrients, it's not surprising to see strong research support for strawberry health benefits in three major areas: (1) cardiovascular support and prevention of cardiovascular diseases (2) improved regulation of blood sugar, with decreased risk of type 2 diabetes, and (3) prevention of certain cancer types including breast, cervical, colon, and esophageal cancer.»

National Cancer Institute research has shown that phytochemicals known as indoles found in kale «inhibit the development of cancer in several organs in rats and mice, including the bladder, breast, colon, liver, lung, and stomach.&Cancer Institute research has shown that phytochemicals known as indoles found in kale «inhibit the development of cancer in several organs in rats and mice, including the bladder, breast, colon, liver, lung, and stomach.&cancer in several organs in rats and mice, including the bladder, breast, colon, liver, lung, and stomach.»

Her studies include reviews of vitamin D, soy, flax, green tea, omega - 3 fatty acids, and melatonin for breast and lung cancer, as well as research on the effectiveness of intravenous vitamin C.

Although some research links higher intakes of vitamin E with decreased incidence of breast cancer, an examination of the impact of dietary factors, including vitamin E, on the incidence of postmenopausal breast cancer in > 18,000 women found no benefit from the vitamin [35].

A pioneer in the field of applied medical anthropology, Sydney, along with his wife and co-author, Soma Grismaijer have written numerous groundbreaking books that provide new theories, research, and revelations on disease causation and prevention, including the internationally acclaimed book, Dressed To Kill: The Link Between Breast Cancer and Bras.

We've seen research studies on five specific types of cancer — including bladder cancer, breast cancer, colon cancer, ovarian cancer, and prostate cancer — and intake of cruciferous vegetables (specifically including kale).